MENU
TNXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tonix Pharmaceuticals Holding (TNXP) Ownership - Who owns Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
296.28M
P/E Ratio
0.11
Total Cash
55.02M
Projected Growth
N/A
Total Debt
8.69M
Revenue
11.29M
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash/Share
7.51
Total Debt/Equity
0.58
Revenue/Share
4.54 USD as % of share price
Fundamentals
TNXP
Capitalization
296M
P/E Ratio
0.11
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash
55M
Total Cash/Share
7.51
Total Debt
8.69M
Total Debt/Equity
0.58
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.54%
Revenue
11.3M
ROE
N/A
Book Value
74.2M
P/B Ratio
1.64
Cash Flow
N/A
Earnings
-8.04K
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
156K
Current Ratio
3.33
Current Revenue Per Employee
27398.06
Dividends Per Share - Security
N/A
EBITDA
-76.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
44.90
Revenue To Assets
-115.46
Shares Held By Institutions
6.11M
Shares Outstanding - Current
7.33M
Total Liabilities
20.8M
Total Volume MTD
N/A
Value
1
Gain YTD
22.650
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in developing and manufacturing pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com